Stock listing

Munich:AN6 AnaptysBio, Inc. Aktie

German listing (Munich) of AnaptysBio, Inc. · home listing NASDAQ:ANAB

Follow AnaptysBio, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:ANAB

$49.24 USD +2.63 (+5.6%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ANAB

Past year +109.4% · daily closes, Oct 20, 2025 – Oct 19, 2026, adjusted for splits
Day range
$47.33 – $49.88 USDOct 19, 2026
Volume
468,354 sharesOct 19, 2026
Market value
$1.47B USDAt the close on Oct 19, 2026 · price × 29.90M shares outstanding
52-week range
$20.18 – $72.36 USDLowest and highest trades, Oct 20, 2025 – Oct 19, 2026
AnaptysBio, Inc. logo
Ticker
Munich:AN6
Asset type
Stock
Exchange
Munich
Currency
EUR

What changed lately

Latest news

Jemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer

Oct 19, 2026

Annual Transition Report (Form 10-KT)

Sep 21, 2026

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

Sep 1, 2026

Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update

May 12, 2026

Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors

May 11, 2026

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

May 4, 2026

Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence

Apr 28, 2026

Issued by another party

Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim

Apr 24, 2026

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

Apr 20, 2026

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

Mar 27, 2026

All AnaptysBio, Inc. news

Decks

AnaptysBio, Inc. on 6ix

News releases
24 in the last 12 months · 121 in all · newest Oct 19, 2026 · oldest 2019
Decks
27 decks · latest September 2026

Where AnaptysBio, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ANAB · Home listingNASDAQUnited StatesUSD
gettex:AN6gettexGermanyEUR
Lang & Schwarz:A2AJ8CLang & SchwarzGermanyEUR
LS Exchange:A2AJ8CLS ExchangeGermanyEUR
BMV:ANABBMVMexicoMXN
LSE:0HFQLSEUnited KingdomUSD
Tradegate:AN6TradegateGermanyEUR
BOATS:ANABBOATSUnited StatesUSD
BIVA:ANABBIVAMexicoMXN
Frankfurt:AN6FrankfurtGermanyEUR
Dusseldorf:AN6DusseldorfGermanyEUR
Munich:AN6 · This pageMunichGermanyEUR
Stuttgart:AN6StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about AnaptysBio, Inc.